Welcome to LookChem.com Sign In|Join Free

CAS

  • or

136315-25-8

Post Buying Request

136315-25-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

136315-25-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 136315-25-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,3,1 and 5 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 136315-25:
(8*1)+(7*3)+(6*6)+(5*3)+(4*1)+(3*5)+(2*2)+(1*5)=108
108 % 10 = 8
So 136315-25-8 is a valid CAS Registry Number.

136315-25-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-, (14bS)-

1.2 Other means of identification

Product number -
Other names 1,2,3,4,10,14bS-Hexahydrodibenzo(c,f)pyrazino(1,2-a)azepine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:136315-25-8 SDS

136315-25-8Downstream Products

136315-25-8Relevant articles and documents

Facile Optical Resolution of a Dibenzopyrazinoazepine Derivative and the Nature of Molecular Recognition of Amines by Chiral 2,3-Di-O-(arylcarbonyl)tartaric Acids

Tomori, Hiroshi,Yoshihara, Hisayoshi,Ogura, Katsuyuki

, p. 3581 - 3590 (1996)

A facile optical resolution of racemic 1,2,3,4,10,14b-hexahydrodibenzopyrazinoazepine (1) was developed using 2,3-di-O-benzoyl-D-(-)-tartaric acid ((+)-DBT) as a resolving agent.The resolution efficiency depends remarkably on the (+)-DBT:1 ratio.When (+)-DBT and racemic 1 were mixed in methanol-water (9:1 v/v) in a 1:4 stoichiometry, a crystalline salt consisting of (+)-DBT, (R)-1, methanol, and water in a 1:2:2:2 ratio crystallized preferentially in a fair yield.X-Ray crystallographic analysis showed its highly ordered supramolecular structure: (+)-DBT molecules self-assemble via hydrogen bonding with the aid of water and methanol to form a puckered layer, and stacking of (R)-1 molecules constructs a column which is sandwiched in between the puckered layers.The X-ray crystallographic data reported for the salts that consist of amines and DBT were reinvestigated to reveal that most of the host frameworks derived from DBT have a layer structure similar to the above puckered one.

A Modular Approach to Dibenzo-fused ?-Lactams: Palladium-Catalyzed Bridging-C?H Activation

Huang, Xueliang,Ma, Liyao,Xia, Jiajin,Xin, Luoting,Yu, Yinghua,Zhu, Lei

, p. 18261 - 18266 (2020/08/21)

Tricyclic ring systems possessing a dibenzo structure joined to a seven-membered heterocyclic ring frequently show important biological activities. However, a modular approach to these molecules based on efficient intermolecular reaction of readily available chemicals is lacking. Herein, an unprecedented palladium-catalyzed formal [4+3] annulation for modular construction of these tricyclic systems is described. This reaction features easily accessible reactants (o-haloarylaldehydes and N-tosylhydrazones), broad substrate scope, and excellent functional group compatibility. The synthetic potential is demonstrated by the easy scale-up reactions, late-stage modification of complex molecules, and collective synthesis of bioactive molecules and approved drugs.

Hybrid approach for the design of highly affine and selective dopamine D3 receptor ligands using privileged scaffolds of biogenic amine GPCR ligands

Sasse, Britta C.,Mach, Ulrich R.,Leppaenen, Jukka,Calmels, Thierry,Stark, Holger

, p. 7258 - 7273 (2008/03/27)

A series of compounds containing privileged scaffolds of the known histamine H1 receptor antagonists cetirizine, mianserin, ketotifen, loratadine, and bamipine were synthesized for further optimization as ligands for the related biogenic amine binding dopamine D3 receptor. A pharmacological screening was carried out at dopamine D2 and D3 receptors. In the preliminary testing various ligands have shown moderate to high affinities for dopamine D3receptors, for example, N-(4-{4-[benzyl(phenyl)amino]piperidin-1-yl}butylnaphthalen-2-carboxamide (19a) (hD3 Ki = 0.3 nM; hD2 Ki = 703 nM), leading to a selectivity ratio of 2343.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 136315-25-8